Boletín médico del Hospital Infantil de México最新文献_第3页

Antibody persistence 7 years after hepatitis-A vaccine in children with human immunodeficiency virus infection. 人类免疫缺陷病毒感染儿童接种甲型肝炎疫苗 7 年后的抗体持续性。

IF 0.6

Boletín médico del Hospital Infantil de México Pub Date : 2024-01-01 DOI: 10.24875/BMHIM.23000125

José G Vázquez-Rosales, Alejandra P Melgoza-Salazar, Mariana G-Sámano-Aviña, Victoria E Montaño-Luna, Ma Rosalía Lira-Carmona, Fortino Solórzano-Santos

{"title":"Antibody persistence 7 years after hepatitis-A vaccine in children with human immunodeficiency virus infection.","authors":"José G Vázquez-Rosales, Alejandra P Melgoza-Salazar, Mariana G-Sámano-Aviña, Victoria E Montaño-Luna, Ma Rosalía Lira-Carmona, Fortino Solórzano-Santos","doi":"10.24875/BMHIM.23000125","DOIUrl":"https://doi.org/10.24875/BMHIM.23000125","url":null,"abstract":"Background: HIV-infected children have a higher risk of presenting infections, including the hepatitis A virus (HAV). The inactivated HAV vaccine is immunogenic in immunocompetent hosts; however, there are insufficient studies on the duration of seroprotection in HIV-infected children.Methods: An analytical cohort study was conducted. HIV-1-infected children who received the inactivated HAV vaccine (2 doses) were included. Blood samples were taken for antibody measurement, the first one 28 days after the second dose and another 7 years after the vaccination schedule. Information on viral load, immunological category, weight, height, and response to antiretroviral treatment from diagnosis to the last assessment was obtained.Results: 19 patients were included, with a mean age of 12.6 years (SD ± 2.29). 58% were male. 80% of the patients presented protective immunoglobulin G antibodies against HAV 7-year post-vaccination. The antibody concentration was found to be between 13 and 80 mIU/mL (median of 80 mIU/mL). 52% showed some degree of immunosuppression. There was no statistically significant relationship between the presence of seroprotection and viral load, treatment failure, immunological category, and malnutrition. Twelve patients presented with antiretroviral treatment failure, and in 33% of them, the antibodies did not offer satisfactory seroprotection.Conclusion: 7-year post-vaccination, 80% of HIV-infected children maintain seroprotection titers against HAV.","PeriodicalId":9103,"journal":{"name":"Boletín médico del Hospital Infantil de México","volume":"81 3","pages":"176-181"},"PeriodicalIF":0.6,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141466159","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Progress in medicine and artificial intelligence. 医学和人工智能的进步。

IF 0.6

Boletín médico del Hospital Infantil de México Pub Date : 2024-01-01 DOI: 10.24875/BMHIM.24000007

Leonardo Viniegra-Velázquez

{"title":"Progress in medicine and artificial intelligence.","authors":"Leonardo Viniegra-Velázquez","doi":"10.24875/BMHIM.24000007","DOIUrl":"https://doi.org/10.24875/BMHIM.24000007","url":null,"abstract":"This essay questions, with regard to medicine, the idea of progress as technological development by focusing on people rather than things. It analyzes how the predominance of such an idea of progress converts today's societies to techno-fetishism that degrades community life and medical practice, contributing to the medicalization of social life. It is argued that the realization of technological potentialities depends on their forms of use; that the main motive of technological development is unlimited profit and that priority developments are those that enhance the social control that maintains the status quo. The intelligence as an intelligence quotient is criticized by proposing it as an attribute of the human being as a whole, manifested in the ways of thinking and proceeding of people in their circumstances, where affectivity and critical thinking are essential for their development; it is emphasized that its antecedent is the harmonic concert of planetary life that contrasts with the prevailing human disharmony. It is proposed that artificial intelligence is the most recent creation of techno-fetishism that deposits vital attributes in technology and that its forms of use will accentuate the degradation of human and planetary life. Another idea of medical progress is proposed, based on forms of organization conducive to the development of inquisitive, critical and collaborative skills that promote permanent improvement, whose distant horizon is dignifying progress: spiritual, intellectual, moral and convivial sublimation of collectivities in harmony with the planetary ecosystem.","PeriodicalId":9103,"journal":{"name":"Boletín médico del Hospital Infantil de México","volume":"81 3","pages":"121-131"},"PeriodicalIF":0.6,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141466172","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Guía mexicana para el diagnóstico y el tratamiento del hemangioma infantil. 墨西哥婴儿血管瘤诊断和治疗指南。

IF 0.6

Boletín médico del Hospital Infantil de México Pub Date : 2024-01-01 DOI: 10.24875/BMHIM.24000069

Mirna E Toledo-Bahena, Karen A Camargo-Sánchez, Helena Vidaurri-De la Cruz, Adriana M Valencia-Herrera, M Mar Sáez-de Ocáriz, Mario R Duarte-Abdala, Julieta Osuna-Osuna, Jessica Aranda-Mendoza, Gloria M Rosales-Solís, Gibert Maza-Ramos, M Luz Orozco-Covarrubias, Pablo Lezama-Del Valle, Julio R Erdmenger-Orellana, Rocío Enríquez-García, Pilar Dies-Suárez, Alejandro Celis-Jiménez, Carlos A Mena-Cedillos

{"title":"Guía mexicana para el diagnóstico y el tratamiento del hemangioma infantil.","authors":"Mirna E Toledo-Bahena, Karen A Camargo-Sánchez, Helena Vidaurri-De la Cruz, Adriana M Valencia-Herrera, M Mar Sáez-de Ocáriz, Mario R Duarte-Abdala, Julieta Osuna-Osuna, Jessica Aranda-Mendoza, Gloria M Rosales-Solís, Gibert Maza-Ramos, M Luz Orozco-Covarrubias, Pablo Lezama-Del Valle, Julio R Erdmenger-Orellana, Rocío Enríquez-García, Pilar Dies-Suárez, Alejandro Celis-Jiménez, Carlos A Mena-Cedillos","doi":"10.24875/BMHIM.24000069","DOIUrl":"10.24875/BMHIM.24000069","url":null,"abstract":"Infantile hemangioma is a benign vascular tumor, the most common in childhood, whose natural evolution is the disappearance of the lesion in the pediatric age and which has effective and safe treatments that limit its growth and favor its disappearance at younger ages. Infantile hemangioma continues to be a reason for attention to complications, due to erroneous diagnoses, lack of knowledge of the condition, late referral or fear of the effects of the medications used for its treatment. Furthermore, its presence is normalized without taking into account that it can cause uncertainty, anxiety, feelings of guilt and, as a consequence, a significant impact on the quality of life, mainly in the parents or caregivers of the child. The need for a clinical practice guideline in our country arises from the high presentation of late-remitted complications in infantile hemangioma even with the availability of adequate treatments, the continuous evolution of medicine and the appearance of new evidence. Throughout the guide you will find recommendations regarding the diagnosis, treatment and follow-up of patients with infantile hemangioma, taking into account the paraclinical tests that can be performed, topical or systemic management options, as well as adjuvant therapies. For the first time, objective tools for patient follow-up are included in a guide for the management of infantile hemangioma, as well as to help the first contact doctor in timely referral.","PeriodicalId":9103,"journal":{"name":"Boletín médico del Hospital Infantil de México","volume":"81 Supl 2","pages":"1-28"},"PeriodicalIF":0.6,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141619280","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Analysis of the changes in the management of preterm newborns born in a Spanish third-level hospital in the past 10 years. 过去 10 年西班牙一家三级医院早产新生儿管理变化分析。

IF 0.9

Boletín médico del Hospital Infantil de México Pub Date : 2024-01-01 DOI: 10.24875/BMHIM.23000093

María Santiago-Souto, Rafael García-Mozo, Marta Costa-Romero

{"title":"Analysis of the changes in the management of preterm newborns born in a Spanish third-level hospital in the past 10 years.","authors":"María Santiago-Souto, Rafael García-Mozo, Marta Costa-Romero","doi":"10.24875/BMHIM.23000093","DOIUrl":"https://doi.org/10.24875/BMHIM.23000093","url":null,"abstract":"Background: Preterm newborns require the use of the best and most current strategies to treat and prevent both acute pathology and associated sequelae. This study aimed to compare the differences in the management of preterm newborns over 10 years in a tertiary hospital in Spain and its impact on height, weight, and neurological development in the medium term.Methods: We conducted a retrospective, observational, and analytical study examining the management and clinical variables in preterm newborns under 32 weeks of gestational age who were born in our hospital in 2011 and 2021.Results: Twenty-six newborns were included in the study. Significant differences in magnesium sulfate use, continuous positive airway pressure immediately after birth, and non-invasive mechanical ventilation during hospitalization were observed. Differences were found in the use of parenteral nutrition and the timing of initiation of enteral feeding. We did not observe differences in the neurological or weight evolution in the medium term.Conclusions: Significant differences in managing preterm newborns in these 10 years were observed. Lower mortality and alterations in central nervous system ultrasound and, significantly, less growth retardation during admission in 2021 have been observed; however, it does not manifest with improvement in long-term somatometrics or neurological prognosis.","PeriodicalId":9103,"journal":{"name":"Boletín médico del Hospital Infantil de México","volume":"81 1","pages":"16-22"},"PeriodicalIF":0.9,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140179317","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Drugs and natural products for the treatment of COVID-19 during 2020, the first year of the pandemic. 2020 年，即大流行的第一年，用于治疗 COVID-19 的药物和天然产品。

IF 0.9

Boletín médico del Hospital Infantil de México Pub Date : 2024-01-01 DOI: 10.24875/BMHIM.23000016

Elia G Jaimes-Castelán, Claudia González-Espinosa, Gil A Magos-Guerrero, Isabel Arrieta-Cruz, Manuel Jiménez-Estrada, Ricardo Reyes-Chilpa, Jorge I Castillo-Arellano

{"title":"Drugs and natural products for the treatment of COVID-19 during 2020, the first year of the pandemic.","authors":"Elia G Jaimes-Castelán, Claudia González-Espinosa, Gil A Magos-Guerrero, Isabel Arrieta-Cruz, Manuel Jiménez-Estrada, Ricardo Reyes-Chilpa, Jorge I Castillo-Arellano","doi":"10.24875/BMHIM.23000016","DOIUrl":"https://doi.org/10.24875/BMHIM.23000016","url":null,"abstract":"This work aimed to show which treatments showed efficacy against coronavirus disease 2019 (COVID-19); therefore, the results of 37 clinical trials started in 2020 and completed in 2021 are reviewed and discussed here. These were selected from databases, excluding vaccines, computational studies, in silico, in vitro, and those with hyperimmune sera from recovered patients. We found 34 drugs, one vitamin, and one herbal remedy with pharmacological activity against symptomatic COVID-19. They reduced mortality, disease progression, or recovery time. For each treatment, the identifier and type of trial, the severity of the disease, the sponsor, the country where the trial was conducted, and the trial results are presented. The drugs were classified according to their mechanism of action. Several drugs that reduced mortality also reduced inflammation in the most severe cases. These include some that are not considered anti-inflammatory, such as Aviptadil, pyridostigmine bromide, anakinra, imatinib, baricitinib, and bevacizumab, as well as the combination of ivermectin, aspirin, dexamethasone, and enoxaparin. Nigella sativa seeds with honey have also been reported to have therapeutic activity. On the other hand, tofacitinib, novaferon with ritonavir, and lopinavir were also effective, as well as in combination with antiviral therapies such as danoprevir with ritonavir. The natural products colchicine and Vitamin D3 were only effective in patients with mild-to-moderate COVID-19, as was hydroxychloroquine. Drug repositioning has been the main tool in the search for effective therapies by expanding the pharmacological options available to patients.","PeriodicalId":9103,"journal":{"name":"Boletín médico del Hospital Infantil de México","volume":"81 1","pages":"53-72"},"PeriodicalIF":0.9,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140179377","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Association of oropharyngeal colostrum administration with decreased inflammatory indices in premature newborns weighing less than 1500 g. 口咽初乳与体重不足 1500 克的早产新生儿炎症指数下降的关系

IF 0.6

Boletín médico del Hospital Infantil de México Pub Date : 2024-01-01 DOI: 10.24875/BMHIM.23000048

Guadalupe Gómez-Rodríguez, Juan L Moreno-Saldaña, Evaldo J Rodríguez-Mejía, Marco A Olvera-Olvera

{"title":"Association of oropharyngeal colostrum administration with decreased inflammatory indices in premature newborns weighing less than 1500 g.","authors":"Guadalupe Gómez-Rodríguez, Juan L Moreno-Saldaña, Evaldo J Rodríguez-Mejía, Marco A Olvera-Olvera","doi":"10.24875/BMHIM.23000048","DOIUrl":"10.24875/BMHIM.23000048","url":null,"abstract":"Background: The administration of colostrum through its absorption at the oropharyngeal level stimulates the mucosa-associated lymphoid tissue, providing a local immunological protection barrier. The study aimed to investigate the association of oropharyngeal colostrum administration with the reduction of inflammatory indices.Materials and methods: This was an observational, ambispective, analytical study of newborns < 32 weeks of gestation at risk of sepsis. Oropharyngeal colostrum was administered at 0.2 mL every 4 h for 5 days. Inflammatory indices were analyzed. Statistical analysis included frequencies, percentages, mean and Standard deviation, contingency coefficient, and Kolmogorov-Smirnov test for the distribution curve of the numerical data.Results: There were 50 patients, 33 (66%) female and 17 (34%) male, with a median gestational age of 30-31 weeks (95% confidence interval [CI]). Nineteen patients had sepsis. A lower positivity rate in C-reactive protein was found, with a median of 0.5-0.6 (95% CI) at 5 days of colostrum administration versus 0.5-1.1 (95% CI) as the initial C-reactive protein. Analysis with χ2 yielded a p = 0.13, and the contingency coefficient showed a p = 0.196, indicating an association.Conclusion: Oropharyngeal colostrum administration was associated with a lower C-reactive protein positivity rate and clinical improvement in premature newborns at risk of sepsis.","PeriodicalId":9103,"journal":{"name":"Boletín médico del Hospital Infantil de México","volume":"81 3","pages":"170-175"},"PeriodicalIF":0.6,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141466160","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Prevalence of secondary arterial hypertension in patients with acute renal failure in a secondary-level pediatric hospital in Northwestern Mexico. 墨西哥西北部一家二级儿科医院急性肾功能衰竭患者继发性动脉高血压的患病率。

IF 0.6

Boletín médico del Hospital Infantil de México Pub Date : 2024-01-01 DOI: 10.24875/BMHIM.23000013

Humberto Peña-Guevara, Iyali M Corrales-Cambero, Saúl Cañizales-Muñoz

{"title":"Prevalence of secondary arterial hypertension in patients with acute renal failure in a secondary-level pediatric hospital in Northwestern Mexico.","authors":"Humberto Peña-Guevara, Iyali M Corrales-Cambero, Saúl Cañizales-Muñoz","doi":"10.24875/BMHIM.23000013","DOIUrl":"10.24875/BMHIM.23000013","url":null,"abstract":"Background: The worldwide prevalence of arterial hypertension in pediatric patients is 3.5%, and it has repercussions at renal, cardiovascular, neurological, and lifestyle levels. This study aimed to estimate the prevalence of arterial hypertension, mortality, and follow-up in patients with acute renal failure in the nephrology outpatient clinic at a second-level hospital in Northwestern Mexico.Methods: We conducted a descriptive, retrospective, and observational study. Men and women aged 1-18 years diagnosed with acute kidney injury were analyzed from January 1, 2012, to December 31, 2021. The medical and electronic records of the candidate patients were analyzed, and nutritional data, laboratory analysis, most frequent etiology, and follow-up in the pediatric nephrology clinic were collected. Those with exacerbated chronic kidney disease and previous diagnosis of high blood pressure were excluded.Results: One hundred and seventy-four patients were evaluated, and only 40 were eligible for the study (22.98%), predominantly males with a mean age of 9.9 years. The degree of arterial hypertension was 50% for grade I and 50% for grade II (p = 0.007); the mortality rate was 32%. One hundred percent of hypertension cases were controlled at 6 months after discharge (p = 0.000080).Conclusions: Our results were similar to those reported in other studies. Follow-up and early detection of arterial hypertension in children need to be strengthened.","PeriodicalId":9103,"journal":{"name":"Boletín médico del Hospital Infantil de México","volume":"81 3","pages":"151-161"},"PeriodicalIF":0.6,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141466163","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Anemia in children with obesity: is there a higher risk compared to eutrophic children? 肥胖儿童贫血：与富营养儿童相比，肥胖儿童患贫血的风险更高吗？

IF 0.6

Boletín médico del Hospital Infantil de México Pub Date : 2024-01-01 DOI: 10.24875/BMHIM.24000121

Daniel A Jaramillo-Bermeo, Melissa Zavala-Rodríguez, Nadia Gutiérrez-Galicia, Lénica A Chávez-Aguilar, Rubén Peña-Vélez

引用次数: 0

Vascular malformations in pediatric patients: 10-year experience of a vascular anomalies clinic. 儿科血管畸形：血管畸形诊所的十年经验。

IF 0.6

Boletín médico del Hospital Infantil de México Pub Date : 2024-01-01 DOI: 10.24875/BMHIM.23000144

Sofía Valdés-Loperena, Adolfo E Lizardo-Rodríguez, Carlos G Hinojosa-Gutiérrez, Max A Bernal-Moreno, Gerardo A Montejo-Ruiz, Manuel Guerrero-Hernández, Jaime Shalkow-Klincovstein, Rodrigo Díaz-Machorro, Daniel Hernández-Arrazola, José M Palacios-Acosta, Oscar Colín-Martínez, Gerardo Fernández-Sobrino, Ana M Borbolla-Pertierra, Carola Durán-Mc Kinster, María Teresa García-Romero

{"title":"Vascular malformations in pediatric patients: 10-year experience of a vascular anomalies clinic.","authors":"Sofía Valdés-Loperena, Adolfo E Lizardo-Rodríguez, Carlos G Hinojosa-Gutiérrez, Max A Bernal-Moreno, Gerardo A Montejo-Ruiz, Manuel Guerrero-Hernández, Jaime Shalkow-Klincovstein, Rodrigo Díaz-Machorro, Daniel Hernández-Arrazola, José M Palacios-Acosta, Oscar Colín-Martínez, Gerardo Fernández-Sobrino, Ana M Borbolla-Pertierra, Carola Durán-Mc Kinster, María Teresa García-Romero","doi":"10.24875/BMHIM.23000144","DOIUrl":"10.24875/BMHIM.23000144","url":null,"abstract":"Background: Vascular malformations (VaMs) are caused by errors in vascular morphogenesis. Diagnosis and treatment can be complex. Few specialized centers care for these patients, and limited literature exists regarding their characteristics and clinical course. The vascular anomalies clinic (VAC) at the Instituto Nacional de Pediatría (National Institute for Pediatrics) is a multidisciplinary team and has been a reference center for patients with VaMs since 2012. We sought to describe the characteristics of patients cared for at the VAC, types of VaMs, treatments used, and clinical course.Methods: This was a descriptive, observational, retrospective, and cross-sectional study conducted from 2012 to 2022.Results: We included 435 patients with VaMs; the median age of presentation was 1 month. The most frequent signs and symptoms were increased volume (97.2%), superficial color change (65.5%), and pain (43.3%). The most common VaMs were lymphatic (36.7%) and venolymphatic (18.3%). Sclerotherapy was the most frequent treatment (73.4%), followed by medical treatment with sirolimus (18.5%); response to both was excellent/good in > 85% of cases.Conclusion: In this retrospective study of children with VaMs, we found that low-flow malformations were the most common, and sclerotherapy and sirolimus were the most frequently used treatments. The therapeutic response was excellent/good in most cases.","PeriodicalId":9103,"journal":{"name":"Boletín médico del Hospital Infantil de México","volume":"81 4","pages":"232-244"},"PeriodicalIF":0.6,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142139300","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Changes in Neonatal Intensive Care Unit statistics during the COVID-19 pandemic. COVID-19 大流行期间新生儿重症监护室统计数据的变化。

IF 0.9

Boletín médico del Hospital Infantil de México Pub Date : 2024-01-01 DOI: 10.24875/BMHIM.M2300003

David Rodríguez-Medina, Luis M Avalos-Huizar, Wendy Bolio-Pontigo, Ma Guadalupe Soto-Castañeda, Julio C Cárdenas-Valdez, Claudia K Medina-Ríos

{"title":"Changes in Neonatal Intensive Care Unit statistics during the COVID-19 pandemic.","authors":"David Rodríguez-Medina, Luis M Avalos-Huizar, Wendy Bolio-Pontigo, Ma Guadalupe Soto-Castañeda, Julio C Cárdenas-Valdez, Claudia K Medina-Ríos","doi":"10.24875/BMHIM.M2300003","DOIUrl":"https://doi.org/10.24875/BMHIM.M2300003","url":null,"abstract":"Background: With the identification of COVID-19 disease in China, a pandemic began that affected health-care systems. The Neonatal Intensive Care Unit (NICU) of the Hospital de Ginecobstetricia del Centro Médico Nacional de Occidente experienced an increase in patient flow as part of the COVID-19 strategy of the Instituto Mexicano del Seguro Social (IMSS). This study aimed to analyze the impact of the COVID-19 pandemic on neonatal care and mortality indicators in our unit.Methods: We conducted a retrospective study to compare the number of hospital births, pre-term newborns (PTNB), NICU admissions, and deaths. Changes in frequencies between 2019 and 2021 were analyzed using Poisson distribution. Changes in PTNB births, proportion of admissions, and deaths/NICU discharges were analyzed by z-test for two proportions.Results: Between 2019 and 2021, the number of births increased by more than 2-fold. NICU admissions increased from 770 in 2019 to 1045 in 2021 (p < 0.01). The ratio of deaths/discharge from the service was 16.9% in 2019 and 13.1% in 2021 (p = 0.02).Conclusions: Mortality indicators in the NICU decreased from 2019 to 2021, even with the increase in the number of patients admitted during the COVID-19 pandemic.","PeriodicalId":9103,"journal":{"name":"Boletín médico del Hospital Infantil de México","volume":"81 1","pages":"31-35"},"PeriodicalIF":0.9,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140179318","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0